Follow
Abhithaj J
Abhithaj J
kannur university
Verified email at kannuruniv.ac.in
Title
Cited by
Cited by
Year
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
KG Arun, CS Sharanya, J Abhithaj, D Francis, C Sadasivan
Journal of Biomolecular Structure and Dynamics 39 (13), 4647-4658, 2021
572021
Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda
M Haridas, V Sasidhar, P Nath, J Abhithaj, A Sabu, P Rammanohar
Future journal of pharmaceutical sciences 7 (1), 1-9, 2021
352021
Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro.
A J, D Francis, EJ Variyar
Journal of Biomolecular Structure & Dynamics, 1-12, 2020
12*2020
Drug repurposing to identify therapeutics against COVID 19 with SARS-Cov-2 spike glycoprotein and main protease as targets: an in silico study
CS Sharanya, J Abhithaj, C Sadasivan
72020
Biochemical and computational insights of adenosine deaminase inhibition by Epigallocatechin gallate
KG Arun, CS Sharanya, J Abhithaj, C Sadasivan
Computational Biology and Chemistry 83, 107111, 2019
42019
Repurposing Simeprevir, Calpain Inhibitor IV and a Cathepsin F Inhibitor Against SARS-CoV-2: A Study Using in Silico Pharmacophore Modeling and Docking Methods
A J, A G, D Francis, S CS, J Variyar
ChemRxiv, 2020
3*2020
Isozymes inhibited by active site blocking: versatility of calcium indifferent hesperidin binding to phospholipase A2 and its significance
J Abhithaj, KG Arun, CS Sharanya, M Haridas, E Jayadevi Variyar
Journal of Receptors and Signal Transduction 39 (1), 60-66, 2019
22019
In silico and in vitro validation of some benzimidazole derivatives as adenosine deaminase inhibitors
A Kumar G, S CS
Indian Journal of Chemistry-Section B (IJC-B) 59 (8), 1175-1182, 2020
12020
Drug repurposing for COVID-19 from FDA approved and experiment stage drugs by in silico methods with SARS CoV-2 spike protein
CS Sharanya, J Abhithaj, A Sabu, H Madathilkovilakathu
12020
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening and molecular docking with main protease as the target
CS Sharanya, J Abhithaj, D Francis, C Sadasivan
12020
Repurposing of Streptomyces antibiotics as adenosine deaminase inhibitors by pharmacophore modeling, docking, molecular dynamics, and in vitro studies
KG Arun, CS Sharanya, J Abhithaj, C Sadasivan
Journal of Receptors and Signal Transduction 40 (1), 77-88, 2020
12020
COVID-19 Omicron variant-inhibitory in silico evidence for phytocompounds of an ancient Ayurvedic formulation
CS Sharanya, J Abhitaj, A Sabu, M Haridas
2022
Drug Repurposing Against SARS-CoV-2 Using E-Pharmacophore Based Virtual Screening and Molecular Docking with Main Protease as the Target
J Abhithaj, F Dileep, C Sadasivan
2020
Drug Repurposing to Identify Therapeutics Against COVID 19 with SARS-Cov-2 Spike Glycoprotein and Main Protease as Targets: An in Silico Study
J Abhithaj, C Sadasivan
2020
Computational Studies on Structural Basis of Isoniazid Resistance in Tuberculosis
V Rajasekharan, J Abhithaj, G Renganayaki, V Thomas
Prospects in Bioscience: Addressing the Issues, 151-157, 2012
2012
A tale of two medicinal plants: A comparative study of medicinal bioactivity of homoeopathic tinctures of Coleus aromaticus and Coleus zeylanicus
T Shikha Ramesh, J Abhithaj, M Kiran, CS Sharanya
The system can't perform the operation now. Try again later.
Articles 1–16